PLIANT THERAPEUTICS, INC.

Profile

Company Names

PLIANT THERAPEUTICS, INC.

Addresses

260 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

650-481-6770

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$162,593,460.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2019-12-19 
$100,445,146.00 
$100,445,146.00 
$0.00 
Equity 
1
2018-07-10 
$62,148,314.00 
$62,148,314.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SUZANNE 
 
BRUHN 
DIRECTOR
PLIANT THERAPEUTICS, INC.   |  VIGIL NEUROSCIENCE, INC.   |  MIND MEDICINE (MINDMED) INC.
BERNARD 
 
COULIE 
EXECUTIVE OFFICER, DIRECTOR
MYOSCIENCE INC   |  MYOSCIENCE, INC   |  PLIANT THERAPEUTICS, INC.
GAYLE 
 
CROWELL 
DIRECTOR
YODLEE INC   |  TRADECARD INC   |  MERCURYGATE INTERNATIONAL INC   |  PLIANT THERAPEUTICS, INC.
KEITH 
 
CUMMINGS 
EXECUTIVE OFFICER
RAM REALTY PARTNERS V LP   |  RAM REALTY V REIT   |  PLIANT THERAPEUTICS, INC.
JOHN 
 
CURNUTTE 
DIRECTOR
3-V BIOSCIENCES, INC.   |  PLIANT THERAPEUTICS, INC.
NEIL 
 
EXTER 
DIRECTOR
SEVENTH SENSE BIOSYSTEMS, INC.   |  CORIDEA NC1, INC.   |  CYTOMX THERAPEUTICS, INC.   |  ELEMENT SCIENCE, INC.   |  RHYTHM METABOLIC, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  GOLDFINCH BIOPHARMA, INC.   |  PLIANT THERAPEUTICS, INC.   |  THIRD ROCK VENTURES V, L.P.   |  REVOLUTION MEDICINES, INC.   |  GOLDFINCH BIO, INC.   |  CEDILLA THERAPEUTICS, INC.   |  DECIBEL THERAPEUTICS, INC.   |  THIRD ROCK VENTURES VI, L.P.
CHARLES 
 
HOMCY 
DIRECTOR
PORTOLA PHARMACEUTICALS INC   |  CYTOMX THERAPEUTICS, INC.   |  MYOKARDIA INC   |  PLIANT THERAPEUTICS, INC.   |  FAZE MEDICINES, INC.
BARBARA 
 
HOWES 
EXECUTIVE OFFICER
PLIANT THERAPEUTICS, INC.   |  EIKON THERAPEUTICS, INC.
HOYOUNG 
 
HUH 
DIRECTOR
CALIBRA MEDICAL, INC.   |  JENNEREX, INC.   |  CYTOMX THERAPEUTICS, INC.   |  ANTRIABIO, INC.   |  RESET THERAPEUTICS, INC.   |  NUVESSE SKIN THERAPIES, INC.   |  JUUL LABS, INC.   |  REZOLUTE, INC.   |  EIDOS THERAPEUTICS, INC.   |  PLIANT THERAPEUTICS, INC.   |  AKARI THERAPEUTICS PLC
JOHANNES 
 
HULL 
EXECUTIVE OFFICER
PLIANT THERAPEUTICS, INC.
ERIC 
 
LEFEBVRE 
EXECUTIVE OFFICER
PLIANT THERAPEUTICS, INC.
KEVIN 
 
RAIDY 
DIRECTOR
SEMMA THERAPEUTICS, INC.   |  PLIANT THERAPEUTICS, INC.   |  COWEN HEALTHCARE INVESTMENTS III LP   |  CHI EF III LP   |  ESCIENT PHARMACEUTICALS INC   |  ARO BIOTHERAPEUTICS CO   |  COWEN HEALTHCARE INVESTMENTS IV LP   |  CHI EF IV LP   |  LATIGO BIOTHERAPEUTICS, INC.
SMITAL 
 
SHAH 
DIRECTOR
PLIANT THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-03-11
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-12-19 
2020-01-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-12-19 
2018-07-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-10 
2018-07-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#